《中国心血管病报告2018》概要

Summary of the 2018 Report on Cardiovascular Diseases in China

中国心血管病防治工作在取得初步成效的同时,又面临新的严峻挑战。总体上看,中国心血管病患病率及死亡率仍处于上升阶段。推算心血管病现患人数2.9亿,其中脑卒中1 300万,冠心病1 100万,肺原性心脏病500万,心力衰竭450万,风湿性心脏病250万,先天性心脏病200万,高血压2.45亿;心血管病死亡率居首位,高于肿瘤及其他疾病,占居民疾病死亡构成的40%以上,特别是农村近几年来心血管病死亡率持续高于城市。心脑血管病住院总费用也在快速增加,2004年至今,年均增速远高于国民生产总值增速。中国心血管病负担日渐加重,已成为重大的公共卫生问题,防治心血管病刻不容缓。

Even though the prevention and control of cardiovascular diseases (CVD) has made preliminary achievements, it is confronted with several new severe challenges. The prevalence and mortality of CVD in China is continuously rising. It is estimated that about 290 million patients suffer from CVD. The number of patients suffering from stroke, coronary heart disease, pulmonary heart disease, heart failure, rheumatic heart disease, congenital heart disease and hypertension are 13 million, 11 million, 5 million, 4.5 million, 2.5 million, 2 million and 245 million, respectively. CVD was still the leading cause of death in 2016, more than tumors or any other diseases. CVD-related deaths accounting for all deaths were more than 40%. The CVD mortality rate in rural areas has exceeded and consistently remained higher than that of urban areas in recent years. The total expenditure on CVD hospitalization has also increased rapidly. Since 2004, the average annual increment speed in CVD costs has been much higher than that of China's gross domestic product. The increased burden of CVD has become the most important public health issue in China, which should be prevented and controlled urgently.